<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Kyoto Medical Center 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=23502></link><description><![CDATA[Kyoto Medical Center 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 16 May 2026 00:02:00 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2014/10/740813719_20141020110334_1392587921.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Clinical Trial at Kyoto Medical Center Proves Efficacy of Curcumin in Knee Osteoarthritis]]></title><link>https://www.newswire.co.kr/newsRead.php?no=770407</link><description><![CDATA[KYOTO, Japan--(Business Wire/Korea Newswire)--The Orthopedics Division at National Hospital Organization, Kyoto Medical Center, announced that it has confirmed the efficacy of Theracrumin®, absorption enhanced curcumin*1 on knee osteoarthritis, based on the clinical trial conducted by the group of researchers.  Knee osteoarthritis is a disease that provokes pains in knee junctions and carti...]]></description><pubDate>Mon, 20 Oct 2014 11:05:00 +0900</pubDate></item><item><title><![CDATA[교토 메디컬센터, 임상시험 통해 커큐민의 퇴행성 무릎 관절염 치료 효과 입증]]></title><link>https://www.newswire.co.kr/newsRead.php?no=770409</link><description><![CDATA[교토, 일본--(Business Wire/뉴스와이어)--국립 의료 기관인 교토 메디컬센터(Kyoto Medical Center) 정형외과는 연구진의 임상시험에서 커큐민*1의 흡수율을 높인 ‘테라큐민’(Theracurmin® )이 퇴행성 무릎 관절염에 효과가 있음이 확인됐다고 발표했다.   퇴행성 무릎 관절염은 무릎 관절과 연골에 통증을 일으키는 질환으로 노화가 주요 원인이며 일본 내 환자수가 2000만 명에 이르는 것으로 알려져 있다. 현재 ...]]></description><pubDate>Mon, 20 Oct 2014 11:05:00 +0900</pubDate></item></channel></rss>